TDSNCT06744049
Transfer Direct System as a New Method for Embryo Transfer
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 12 words
- Study sites: 4 to 5
- Study description expanded, about 10 words
- Minor Site details revised at 1 of 4 sitesv4
- Notable Primary completion date: Aug 2025 to Dec 2026
- Study sites: 3 to 4
- Study completion date: Aug 2025 to Mar 2027
- Minor Study sites: 2 to 3
- Primary completion date: Jun 2025 to Aug 2025
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Safety of TDS in comparison with conventional transfer
Timeframe: From enrollment to final study visit at 8-10 weeks of pregnancy
Secondary (4)
Efficacy and non-inferiority of TDS
pregnancy rate
ongoing gestation rate
miscarriage rate
Arms and interventions
Embryo transfer with Transfer Direct System (TDS)Experimental
The trial has a single assignment group aimed at patients of reproductive age who attend the clinic with a desire for a child and undergo Assisted Reproduction Treatment (ART) with an euploid single embryo transfer (SET) after corresponding hormone replacement therapy (HRT) has been carried out.
Devices: Transfer Direct System (TDS)
Sites
5 sites in 1 country